Novartis data shows ACZ885 for severe gouty arthritis provided better pain relief and reduced risk of new attacks by up to 68% vs. steroid

Novartis data shows ACZ885 for severe gouty arthritis provided better pain relief and reduced risk of new attacks by up to 68% vs. steroid

May 25, 2011
Source URL: https://qa1.novartis.us/us-en/news/media-releases/novartis-data-shows-acz885-severe-gouty-arthritis-provided-better-pain-relief-and-reduced-risk-new-attacks-68-vs-steroid-0

List of links present in page
  1. https://qa1.novartis.us/us-en/us-en/news/media-releases/novartis-data-shows-acz885-severe-gouty-arthritis-provided-better-pain-relief-and-reduced-risk-new-attacks-68-vs-steroid-0